CXCL9 and tuberculosis: According to our current study, it is conceivable that type I IFN signaling might downregulate IFN-γ-mediated expression of CXCL9 and CXCL10 in innate immune cells, thereby hindering the migration of Mtb-specific T cells into the lung and finally leading to severe TB pathogenesis.